Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aveeno Dermexa Fast & Long-Lasting Balm is a topical skincare product developed by Kenvue under the Aveeno brand, specifically formulated for very dry, itchy, and eczema-prone skin. The formulation features a Triple Oat Complex—comprising avenanthramides, oat oil, and colloidal oatmeal (Avena sativa)—combined with ceramides. It functions as an emollient and skin barrier restorer, clinically proven to provide itch relief for up to 6 hours and improve the skin barrier within one week. It is suitable for use in adults, children, and infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aveeno Dermexa Fast & Long-Lasting Balm.